ESSA Pharma Inc.
ESSA Pharma Inc. (EPIX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EPIX · as of Jun 9, 2026
Key Statistics
Explore ESSA Pharma Inc. Data
epix stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 40.0%
The EPIX analyst consensus is Hold, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $9.50, representing +4621.67% upside from the current price of $0.20.
Competitors & Peers
epix competitorsEPIX
APGN
BIOR
CHRO
CRVO
CSCIStock Performance
Full HistoryAbout ESSA Pharma Inc.
ESSA Pharma Inc. (EPIX) functions as a clinical-stage pharmaceutical firm, concentrating its efforts on developing innovative and exclusive therapies designed to combat prostate cancer. The company's …
what is essa pharma inc. · epix stock overview · essa pharma inc. company profile · who is essa pharma inc. ceo · epix NASDAQ · essa pharma inc. headquarters · essa pharma inc. business segments
About Stock Overview & Key Data
ESSA Pharma Inc. (EPIX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 13, 2015. As of the latest trading session, EPIX stock price is $0.20, with a market capitalization of $9.5M. The stock has returned -89.18% over the past 12 months and -89.01% year-to-date.
According to 5 Wall Street analysts, the consensus rating for ESSA Pharma Inc. stock is Hold, with an average 12-month price target of $9.50. In fiscal year 2024, ESSA Pharma Inc. reported revenue of — and net income of -$28.5M. For detailed data — including ESSA Pharma Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ESSA Pharma Inc. (EPIX) stock price is $0.20. The stock is traded on NASDAQ under the ticker symbol EPIX. The 52-week range is $0.18 – $6.45.